Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data
暂无分享,去创建一个
Xiaofeng Li | Feng Zhu | Yunxia Wang | Jing Tang | Weiwei Xue | Jie Hu | Yunqing Qiu | Yuzong Chen | Bo Li | Qingxia Yang | Xuejiao Cui | Yan Lou | Yuzong Chen | Bo Li | Weiwei Xue | Feng Zhu | Jing Tang | Yunxia Wang | Qingxia Yang | Xuejiao Cui | Xiaofen Li | Y. Lou | Jie Hu | Yunqing Qiu
[1] M. Barnes,et al. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function , 2009, Molecular Psychiatry.
[2] E. Thomas,et al. Molecular profiling of antipsychotic drug function , 2006, Molecular Neurobiology.
[3] B. Pickard,et al. Schizophrenia biomarkers: Translating the descriptive into the diagnostic , 2015, Journal of psychopharmacology.
[4] Norio Ozaki,et al. Immunohistochemical evaluation of the GABAergic neuronal system in the prefrontal cortex of a DISC1 knockout mouse model of schizophrenia , 2016, Synapse.
[5] Xing Chen,et al. A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: Evidence from chromosome 3 high density association screen , 2018, The Journal of comparative neurology.
[6] Martin J. Schmidt,et al. Immune system gene dysregulation in autism and schizophrenia , 2012, Developmental neurobiology.
[7] Dmitri Volfson,et al. STEP Levels Are Unchanged in Pre-Frontal Cortex and Associative Striatum in Post-Mortem Human Brain Samples from Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder , 2015, PloS one.
[8] David J. Porteous,et al. Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder , 2017, JAMA psychiatry.
[9] Josef Parnas,et al. Identity Disturbance, Feelings of Emptiness, and the Boundaries of the Schizophrenia Spectrum , 2018, Schizophrenia bulletin.
[10] V. Haroutunian,et al. Variations in differential gene expression patterns across multiple brain regions in schizophrenia , 2005, Schizophrenia Research.
[11] Sirintra Nakjang,et al. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study , 2017, The Lancet. Oncology.
[12] Pedro Larrañaga,et al. Filter versus wrapper gene selection approaches in DNA microarray domains , 2004, Artif. Intell. Medicine.
[13] Feng Zhu,et al. Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs , 2019, Briefings Bioinform..
[14] Sarven Sabunciyan,et al. Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays , 2008, BMC psychiatry.
[15] Anat Levit,et al. STRUCTURE OF THE D2 DOPAMINE RECEPTOR BOUND TO THE ATYPICAL ANTIPSYCHOTIC DRUG RISPERIDONE , 2018, Nature.
[16] Murray J. Cairns,et al. Upregulation of Dicer and MicroRNA Expression in the Dorsolateral Prefrontal Cortex Brodmann Area 46 in Schizophrenia , 2011, Biological Psychiatry.
[17] Benjamin M. Bolstad,et al. affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..
[18] Jesse Gillis,et al. Genome-wide expression profiling of schizophrenia using a large combined cohort , 2011, Molecular Psychiatry.
[19] Jens Roat Kultima,et al. Potential of fecal microbiota for early‐stage detection of colorectal cancer , 2014 .
[20] Kazuya Iwamoto,et al. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. , 2005, Human molecular genetics.
[21] Pat Levitt,et al. Molecular Evidence for Increased Expression of Genes Related to Immune and Chaperone Function in the Prefrontal Cortex in Schizophrenia , 2007, Biological Psychiatry.
[22] Mao Sheng Yang,et al. Association between schizophrenia and single nucleotide polymorphisms in lipoprotein lipase gene in a Han Chinese population , 2011, Psychiatric genetics.
[23] L. Ein-Dor,et al. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[24] Martin Kidd,et al. Changes in erythrocyte membrane fatty acids during a clinical trial of eicosapentaenoic acid (EPA) supplementation in schizophrenia , 2009, Metabolic Brain Disease.
[25] T. Hashimoto,et al. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia , 2006, Molecular Psychiatry.
[26] Jacques Corbeil,et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] Sam Richman,et al. An online database for brain disease research , 2006, BMC Genomics.
[28] Bo Li,et al. NOREVA: normalization and evaluation of MS-based metabolomics data , 2017, Nucleic Acids Res..
[29] Pedro Larrañaga,et al. A review of feature selection techniques in bioinformatics , 2007, Bioinform..
[30] Susan Michie,et al. Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial. , 2018, The lancet. Psychiatry.
[31] Tingting Fu,et al. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics , 2017, Nucleic Acids Res..
[32] Stelios Pavlidis,et al. Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer , 2018, Front. Immunol..
[33] Yong-Gang Yao,et al. SZDB: A Database for Schizophrenia Genetic Research , 2016, Schizophrenia bulletin.
[34] Ronald L Klein,et al. Cre‐dependent AAV vectors for highly targeted expression of disease‐related proteins and neurodegeneration in the substantia nigra , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] David A Lewis,et al. Transcriptome alterations in the prefrontal cortex of subjects with schizophrenia who committed suicide. , 2008, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology.
[36] Steven R. Head,et al. Molecular profiles of schizophrenia in the CNS at different stages of illness , 2008, Brain Research.
[37] M. Cairns,et al. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells , 2011, Molecular Psychiatry.
[38] Eric S. Lander,et al. A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.
[39] Bharti,et al. fMRI based computer aided diagnosis of schizophrenia using fuzzy kernel feature extraction and hybrid feature selection , 2017, Multimedia Tools and Applications.
[40] Hugo G. Schnack,et al. Improving individual predictions: Machine learning approaches for detecting and attacking heterogeneity in schizophrenia (and other psychiatric diseases) , 2017, Schizophrenia Research.
[41] David A. Lewis,et al. Altered Cortical CDC42 Signaling Pathways in Schizophrenia: Implications for Dendritic Spine Deficits , 2010, Biological Psychiatry.
[42] Feng Xu,et al. Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information , 2015, Nucleic Acids Res..
[43] Feng Zhu,et al. Identification of Key Long Non-Coding RNAs in the Pathology of Alzheimer's Disease and their Functions Based on Genome-Wide Associations Study, Microarray, and RNA-seq Data. , 2019, Journal of Alzheimer's disease : JAD.
[44] Christopher H Woelk,et al. A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. , 2012, Journal of psychiatric research.
[45] Johan A. K. Suykens,et al. Systematic benchmarking of microarray data classification: assessing the role of non-linearity and dimensionality reduction , 2004, Bioinform..
[46] Simon C. Potter,et al. Genome-wide Association Analysis Identifies 14 New Risk Loci for Schizophrenia , 2013, Nature Genetics.
[47] Cangzhi Jia,et al. 4mCPred: machine learning methods for DNA N4‐methylcytosine sites prediction , 2018, Bioinform..
[48] R. Yolken,et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress , 2004, Molecular Psychiatry.
[49] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[50] Pat Levitt,et al. Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.
[51] Dan Cohen,et al. Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia , 2018, Molecular Psychiatry.
[52] Juan Cui,et al. Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation. , 2007, Cancer research.
[53] Feng Zhu,et al. Clinical Success of Drug Targets Prospectively Predicted by In Silico Study. , 2017, Trends in pharmacological sciences.
[54] Murray J. Cairns,et al. MicroRNA and Posttranscriptional Dysregulation in Psychiatry , 2015, Biological Psychiatry.
[55] P. Kinnunen,et al. Increased serum phospholipase A2 activity in schizophrenia: a replication study. , 1990, Biological psychiatry.
[56] K. Lindblad-Toh,et al. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals , 2005, Nature.
[57] M. Hill,et al. Knockdown of the schizophrenia susceptibility gene TCF4 alters gene expression and proliferation of progenitor cells from the developing human neocortex , 2017, Journal of psychiatry & neuroscience : JPN.
[58] Toshikazu Saito,et al. The role of neural stem cells for in vitro models of schizophrenia: Neuroprotection via Akt/ERK signal regulation , 2010, Schizophrenia Research.
[59] Hongyi Zhou,et al. A knowledge-based approach for predicting gene-disease associations , 2016, Bioinform..
[60] Sandra Romero-Steiner,et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines , 2022 .
[61] Nobumasa Kato,et al. Association between the neurofibromatosis‐1 (NF1) locus and autism in the Japanese population , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[62] P. Mortensen,et al. Excess early mortality in schizophrenia. , 2014, Annual review of clinical psychology.
[63] Sylvia Tippmann,et al. Programming tools: Adventures with R , 2014, Nature.
[64] Stefan Michiels,et al. Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.
[65] Hugues Bersini,et al. Batch effect removal methods for microarray gene expression data integration: a survey , 2013, Briefings Bioinform..
[66] Sinead M O’Donovan,et al. Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia , 2018, Molecular Psychiatry.
[67] Jeffrey T Leek,et al. qSVA framework for RNA quality correction in differential expression analysis , 2017, Proceedings of the National Academy of Sciences of the United States of America.
[68] Charles L. Raison,et al. Tyrosine metabolism during interferon-alpha administration: Association with fatigue and CSF dopamine concentrations , 2013, Brain, Behavior, and Immunity.
[69] U. Rapp,et al. The GABP-responsive Element of the Interleukin-2 Enhancer Is Regulated by JNK/SAPK-activating Pathways in T Lymphocytes* , 1998, The Journal of Biological Chemistry.
[70] J. Chun,et al. LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage , 2015, Translational Psychiatry.
[71] M. Butler,et al. Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases. , 2018, Gene.
[72] Q. Zou,et al. Gene2vec: gene subsequence embedding for prediction of mammalian N6-methyladenosine sites from mRNA , 2018, RNA.
[73] Helena Brentani,et al. Innate immune response is differentially dysregulated between bipolar disease and schizophrenia , 2015, Schizophrenia Research.
[74] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[75] Xinzhi Zhao,et al. Positive association between ALDH1A2 and schizophrenia in the Chinese population , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[76] Károly Mirnics,et al. Immune System Disturbances in Schizophrenia , 2014, Biological Psychiatry.
[77] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[78] C. Spencer,et al. Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.
[79] Cameron S Carter,et al. Levels of Cognitive Control: A Functional Magnetic Resonance Imaging-Based Test of an RDoC Domain Across Bipolar Disorder and Schizophrenia , 2018, Neuropsychopharmacology.
[80] Ziyan Shi,et al. STAT4 Polymorphisms are Associated with Neuromyelitis Optica Spectrum Disorders , 2017, NeuroMolecular Medicine.
[81] Murray J Cairns,et al. Optimal consistency in microRNA expression analysis using reference-gene-based normalization. , 2015, Molecular bioSystems.
[82] Klaus Pantel,et al. Data Normalization Strategies for MicroRNA Quantification. , 2015, Clinical chemistry.
[83] Feng Zhu,et al. Performance Evaluation and Online Realization of Data-driven Normalization Methods Used in LC/MS based Untargeted Metabolomics Analysis , 2016, Scientific Reports.
[84] D. Rujescu,et al. Schizophrenia shows a unique metabolomics signature in plasma , 2012, Translational Psychiatry.
[85] Benjamin A. Logsdon,et al. Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia , 2016, Nature Neuroscience.
[86] Noam Shomron,et al. Molecular Risk Factors for Schizophrenia. , 2016, Trends in molecular medicine.
[87] C. Spencer,et al. A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium , 2016, bioRxiv.
[88] Patrick F. Sullivan,et al. Comparative Genomic Evidence for the Involvement of Schizophrenia Risk Genes in Antipsychotic Effects , 2017, Molecular Psychiatry.
[89] Ya-Mei Bai,et al. The coding‐synonymous polymorphism rs1045280 (Ser280Ser) in β‐arrestin 2 (ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia , 2008, European journal of neurology.
[90] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[91] T M Hyde,et al. Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia , 2013, Molecular Psychiatry.
[92] P. D. Rijk,et al. MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets , 2014, Molecular Psychiatry.
[93] Xiaofeng Li,et al. ANPELA: analysis and performance assessment of the label-free quantification workflow for metaproteomic studies , 2019, Briefings Bioinform..
[94] Humberto Nicolini,et al. Comparative Analysis of Gene Expression Profiles Involved in Calcium Signaling Pathways Using the NLVH Animal Model of Schizophrenia , 2017, Journal of Molecular Neuroscience.
[95] Colin Norman,et al. What Don't We Know? , 2005, Science.